Takeda nabs dengue vaccine approval in Europe, as travel, climate change contribute to rise in cases
Takeda’s dengue vaccine Qdenga is now approved in the European Union, following its first approval this summer in Indonesia. The bigger question though, especially for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.